Oracle Insider Notice: 21,241 Shares From Restricted Vesting to Be Sold

Rhea-AI Filing Summary

Oracle insider filing a Form 144 notifies intent to sell 21,241 shares of common stock through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $6,310,864.10 and an approximate sale date of 09/12/2025. The shares were acquired on 08/03/2025 upon restricted stock vesting as compensation. The filer also reported a prior sale of 15,000 shares on 06/17/2025 for gross proceeds of $3,211,483.72. The notice includes the standard attestation that no undisclosed material adverse information is known by the seller.

Insights

Securities Analyst

TL;DR: Insider plans to sell vested restricted shares totaling 21,241 shares (~$6.3M), consistent with scheduled post-vesting disposition.

The Form 144 indicates disposition of recently vested restricted stock by an insider through a broker on the NYSE, with an expected sale date in September 2025. The filing shows a prior related sale of 15,000 shares in June 2025. These transactions reflect routine post-vesting sales for compensation rather than extraordinary corporate events. The size of the planned sale relative to the company’s market capitalization appears limited based on the values disclosed.

Corporate Governance Expert

TL;DR: This is a compliance disclosure of an insider selling vested compensation shares; it carries routine governance implications.

The notice fulfills Rule 144 procedural requirements by specifying acquisition date, nature (restricted stock vesting), broker, and planned sale details. The representation that no undisclosed material adverse information exists is included, and there is no indication of a trading plan or 10b5-1 adoption in the filing text. From a governance perspective, the filing documents transparency around executive compensation monetization.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	21241	6310864.10	2841714000	09/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/03/2025	Restricted Stock Vesting	Issuer			21241	08/03/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Clayton Magouyrk 2300 Oracle Way Austin TX 78741	Common	06/17/2025	15000	3211483.72

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the ORCL Form 144 report propose to sell?

The filing proposes sale of 21,241 shares of Oracle common stock through Fidelity Brokerage Services on the NYSE.

When were the shares acquired that are proposed to be sold in this ORCL Form 144?

The shares were acquired on 08/03/2025 upon restricted stock vesting and classified as compensation.

What is the aggregate market value and approximate sale date in the ORCL Form 144?

The aggregate market value is reported as $6,310,864.10 with an approximate sale date of 09/12/2025.

Did the filer sell other Oracle shares recently according to the Form 144?

Yes; the filing discloses a prior sale of 15,000 shares on 06/17/2025 for gross proceeds of $3,211,483.72.

Was the proposed sale related to a gift or purchase on credit?

No. The filing shows the shares were acquired via restricted stock vesting and payment nature is listed as compensation.